Aspetar Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2009
NCT01812564
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Aspetar | Aspetar, Orthopedic and Sports Medicine Hospital